Molecular Research on Polycystic Ovary Syndrome (PCOS)

Overview

Journal Biomedicines

Specialty Biomedical Engineering

Date 2023 May 27

PMID 37239028

Authors

Simona Daniele

Elisa Chelucci

Giorgia Scarfo

Paolo Giovanni Artini

Affiliations

Soon will be listed here.

Abstract

Polycystic ovary syndrome (PCOS) is an endocrine systemic disorder with a prevalence of between 5% and 20% that commonly affects childbearing-aged women [...].

Citing Articles

PGD: Shared gene linking polycystic ovary syndrome and endometrial cancer, influencing proliferation and migration through glycometabolism.

Chen J, Chen W, Wang Z, Zhou L, Lin Q, Huang Q Cancer Sci. 2024; 115(9):2908-2922.

PMID: 38979884 PMC: 11462980. DOI: 10.1111/cas.16212.

Unveiling Key Biomarkers and Therapeutic Drugs in Polycystic Ovary Syndrome (PCOS) Through Pathway Enrichment Analysis and Hub Gene-miRNA Networks.

Heidarzadehpilehrood R, Pirhoushiaran M, Osman M, Ling K, Hamid H Iran J Pharm Res. 2024; 22(1):e139985.

PMID: 38444712 PMC: 10912876. DOI: 10.5812/ijpr-139985.

References

Petrillo T, Semprini E, Tomatis V, Arnesano M, Ambrosetti F, Battipaglia C . Putative Complementary Compounds to Counteract Insulin-Resistance in PCOS Patients. Biomedicines. 2022; 10(8). PMC: 9406066. DOI: 10.3390/biomedicines10081924. View

Lidaka L, Bekere L, Lazdane G, Lazovska M, Dzivite-Krisane I, Gailite L . Role of Single Nucleotide Variants in the Gene in Adolescents with Polycystic Ovary Syndrome. Biomedicines. 2022; 10(7). PMC: 9312887. DOI: 10.3390/biomedicines10071688. View

Siemienowicz K, Filis P, Thomas J, Fowler P, Duncan W, Rae M . Hepatic Mitochondrial Dysfunction and Risk of Liver Disease in an Ovine Model of "PCOS Males". Biomedicines. 2022; 10(6). PMC: 9220073. DOI: 10.3390/biomedicines10061291. View

Gargus E, Bae Y, Chen J, Moss K, Ingram A, Zhang J . An Ovarian Steroid Metabolomic Pathway Analysis in Basal and Polycystic Ovary Syndrome (PCOS)-like Gonadotropin Conditions Reveals a Hyperandrogenic Phenotype Measured by Mass Spectrometry. Biomedicines. 2022; 10(7). PMC: 9313004. DOI: 10.3390/biomedicines10071646. View

Jensterle M, Herman R, Janez A . Therapeutic Potential of Glucagon-like Peptide-1 Agonists in Polycystic Ovary Syndrome: From Current Clinical Evidence to Future Perspectives. Biomedicines. 2022; 10(8). PMC: 9405922. DOI: 10.3390/biomedicines10081989. View

Abdul Hamid F, Abu M, Abdul Karim A, Ahmad M, Abd Aziz N, Kamal D . Sex Steroid Receptors in Polycystic Ovary Syndrome and Endometriosis: Insights from Laboratory Studies to Clinical Trials. Biomedicines. 2022; 10(7). PMC: 9312843. DOI: 10.3390/biomedicines10071705. View

Vitale S, Fulghesu A, Mikus M, Watrowski R, DAlterio M, Lin L . The Translational Role of miRNA in Polycystic Ovary Syndrome: From Bench to Bedside-A Systematic Literature Review. Biomedicines. 2022; 10(8). PMC: 9405312. DOI: 10.3390/biomedicines10081816. View

Nawrocka-Rutkowska J, Szydlowska I, Jakubowska K, Olszewska M, Chlubek D, Szczuko M . The Role of Oxidative Stress in the Risk of Cardiovascular Disease and Identification of Risk Factors Using AIP and Castelli Atherogenicity Indicators in Patients with PCOS. Biomedicines. 2022; 10(7). PMC: 9312468. DOI: 10.3390/biomedicines10071700. View

Scarfo G, Daniele S, Fusi J, Gesi M, Martini C, Franzoni F . Metabolic and Molecular Mechanisms of Diet and Physical Exercise in the Management of Polycystic Ovarian Syndrome. Biomedicines. 2022; 10(6). PMC: 9219791. DOI: 10.3390/biomedicines10061305. View

10.

Rosenfield R, Ehrmann D . The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited. Endocr Rev. 2016; 37(5):467-520. PMC: 5045492. DOI: 10.1210/er.2015-1104. View

11.

Szczuko M, Pokorska-Niewiada K, Kwiatkowska L, Nawrocka-Rutkowska J, Szydlowska I, Zietek M . Level of Potassium Is Associated with Saturated Fatty Acids in Cell Membranes and Influences the Activation of the 9 and 13 HODE and 5 HETE Synthesis Pathways in PCOS. Biomedicines. 2022; 10(9). PMC: 9496543. DOI: 10.3390/biomedicines10092244. View

12.

Clemente N, Racine C, Rey R . Anti-Müllerian Hormone and Polycystic Ovary Syndrome in Women and Its Male Equivalent. Biomedicines. 2022; 10(10). PMC: 9599141. DOI: 10.3390/biomedicines10102506. View

13.

Glintborg D, Petersen T, Rubin K, Andersen M . Diabetes Mellitus Mediates Risk of Depression in Danish Women with Polycystic Ovary Syndrome-A National Cohort Study. Biomedicines. 2022; 10(10). PMC: 9598722. DOI: 10.3390/biomedicines10102396. View

14.

Feigl S, Obermayer-Pietsch B, Klaritsch P, Pregartner G, Herzog S, Lerchbaum E . Impact of Thyroid Function on Pregnancy and Neonatal Outcome in Women with and without PCOS. Biomedicines. 2022; 10(4). PMC: 9025948. DOI: 10.3390/biomedicines10040750. View

15.

Glintborg D, Kolster N, Ravn P, Andersen M . Prospective Risk of Type 2 Diabetes in Normal Weight Women with Polycystic Ovary Syndrome. Biomedicines. 2022; 10(6). PMC: 9220967. DOI: 10.3390/biomedicines10061455. View

16.

Nautiyal H, Imam S, Alshehri S, Ghoneim M, Afzal M, Alzarea S . Polycystic Ovarian Syndrome: A Complex Disease with a Genetics Approach. Biomedicines. 2022; 10(3). PMC: 8945152. DOI: 10.3390/biomedicines10030540. View

17.

Gleicher N, Darmon S, Patrizio P, Barad D . Reconsidering the Polycystic Ovary Syndrome (PCOS). Biomedicines. 2022; 10(7). PMC: 9313207. DOI: 10.3390/biomedicines10071505. View

18.

Niepsuj J, Franik G, Madej P, Piwowar A, Bizon A . Evaluation of Pro/Antioxidant Imbalance in Blood of Women with Polycystic Ovary Syndrome Based on Determination of Oxidized Low-Density Lipoproteins and Ferric Reducing Ability of Plasma Values. Biomedicines. 2022; 10(7). PMC: 9328171. DOI: 10.3390/biomedicines10071564. View